HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 2.920
-0.130 (-4.26%)
At close: Mar 27, 2026
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.67 billion as of March 27, 2026. Its market cap has increased by 191.96% in one year.
Market Cap
1.67B
Enterprise Value
1.35B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.92
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.67B, a decrease of -73.82%. That is a compound annual growth rate of -44.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.67B | -1.02% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Frontage Holdings | 2.31B |
| Mabpharm | 2.27B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.92B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.92B |
| Cutia Therapeutics | 1.73B |
| Immunotech Biopharm | 1.72B |
| Zhaoke Ophthalmology | 1.60B |
| CANbridge Pharmaceuticals | 1.56B |